v3.26.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
CASH FLOWS FROM OPERATING ACTIVITIES    
Net loss $ (5,398,562) $ (8,244,603)
Adjustments to reconcile net loss to net cash provided by operating activities    
Fair value of vested stock options 807,275 2,843,690
Fair value of vested restricted common stock 1,461,944 1,559,627
Fair value of common stock issued for services 476,037 479,755
Loss on fair value of common stock issued for settlement of vendor 33,750
Change in inventory reserve (5,000)
Amortization of capitalized software costs 367,907 483,832
Right-of-use assets 257,128 236,067
Amortization of intangible assets 1,692,037 1,686,328
Amortization of debt discount 14,717
Accrued interest 2,250 20,632
Changes in operating assets and liabilities:    
Accounts receivable 23,551 101,117
Inventories 285,815 1,318,117
Prepaid expenses and other current assets (160,992) (211,510)
Deposits (6,926)
Accounts payable 306,950 17,029
Accrued expenses (484,581) (113,548)
Customer deposits 70,356 (93,388)
Deferred revenue (31,105) 46,532
Deferred taxes (432,750) (440,574)
Operating lease liability (264,938) (233,637)
Net cash provided by (used in) operating activities (1,033,604) (496,067)
CASH FLOWS FROM INVESTING ACTIVITIES    
Cash received on acquisition 109,543
Net cash provided by (used in) investing activities 109,543
CASH FLOWS FROM FINANCING ACTIVITIES    
Proceeds from line of credit 119,469,093 96,816,921
Repayment of line of credit (119,559,096) (97,928,266)
Proceeds from note payable 985,000
Repayment of notes payable (9,718) (826,323)
Repayment of notes payable – related party (2,000,000)
Proceeds from sale of common stock, net of expenses, under an at-the-market sale agreement 30,593 1,444,077
Proceeds from sale of common stock, net of expenses, under stock purchase agreement 374,500
Proceeds from public offering of common stock 478,000
Proceeds from private placement of common stock 1,393,000 762,000
Net cash provided by financing activities 1,323,872 105,909
Net increase (decrease) in cash and cash equivalents 290,268 (280,615)
Cash and cash equivalents beginning of period 3,654,944 4,301,842
Cash and cash equivalents end of period 3,945,212 4,021,227
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION    
Interest paid 343,358 431,818
Taxes paid
NON-CASH INVESTING AND FINANCING ACTIVITIES    
Common shares issued for acquisition 609,000
Common shares issued for trade accounts payable 108,750
Accounts receivable from acquisition 59,114
Deposits from acquisition 2,633
Accounts payable from acquisition 500
Accrued expenses from acquisition $ 52,953